Home › Kanser sa Cervix › Maryland
Pag-aaral pangklinika para sa Kanser sa Cervix sa Maryland
12 pag-aaral para sa Kanser sa Cervix ang naghahanap ng mga kalahok sa mga site sa Maryland.
Mga Lungsod sa Maryland
Opisyal na teksto ng pag-aaral (English)
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06172478A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Maryland Oncology Hematology (MOH) ( Site 8001), Columbia
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT07216703Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Research Site, Baltimore
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06535607A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- Upper Chesapeake Health, Bel Air
- at 2 pa
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Ago 10, 2026 · NCT07415681A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Hul 1, 2026 · NCT06315257E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT05686226Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Advanced Molecular Imaging and Therapy, Glen Burnie
- United Theranostics - Chesapeake, Glen Burnie
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT05283330PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
- National Institute of Health, Bethesda
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT06157151Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 11, 2026 · NCT03968406Image-Guided Gynecologic Brachytherapy
- The SKCCC at Johns Hopkins, Baltimore
Nagre-recruit
Edad 18 hanggang 100 · Kababaihan · Na-update Dis 18, 2025 · NCT02993900SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.